Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

  • Kentaro Minagawa,
  • Muhammad O. Jamil,
  • Mustafa AL-Obaidi,
  • Larisa Pereboeva,
  • Donna Salzman,
  • Harry P. Erba,
  • Lawrence S. Lamb,
  • Ravi Bhatia,
  • Shin Mineishi,
  • Antonio Di Stasi
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Funding section: A.D. was supported by an American Cancer Society (ACS) New faculty Career Development Grant, and by a “Walter B. Frommeyer Jr. Fellowship in investigative medicine."

Reference

  1. 1. Minagawa K, Jamil MO, AL-Obaidi M, Pereboeva L, Salzman D, Erba HP, et al. (2016) In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS ONE 11(12): e0166891. pmid:27907031

Citation: Minagawa K, Jamil MO, AL-Obaidi M, Pereboeva L, Salzman D, Erba HP, et al. (2017) Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia. PLoS ONE 12(2): e0172640. https://doi.org/10.1371/journal.pone.0172640

Published: February 15, 2017

Copyright: © 2017 Minagawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.